Gene therapy injection aims to slow vision loss from dry AMD
Disease control
Recruiting now
This study tests a new gene therapy (VV-14295) given as an injection into the eye for people with geographic atrophy, a form of advanced dry age-related macular degeneration that causes blind spots. The goal is to see if it is safe and can slow the growth of these spots. About 62…
Phase: PHASE1, PHASE2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC